In the last trading session, 11.11 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) were traded, and its beta was 0.45. Most recently the company’s share price was $0.20, and it changed around $0.03 or 14.66% from the last close, which brings the market valuation of the company to $10.98M. APDN currently trades at a discount to its 52-week high of $22.80, offering almost -11300.0% off that amount. The share price’s 52-week low was $0.14, which indicates that the current value has risen by an impressive 30.0% since then. We note from Applied Dna Sciences Inc’s average daily trading volume that its 10-day average is 6.58 million shares, with the 3-month average coming to 4.43 million.
Applied Dna Sciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended APDN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Applied Dna Sciences Inc is expected to report earnings per share of -0.35 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Instantly APDN has showed a green trend with a performance of 14.66% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.2200 on recent trading dayincreased the stock’s daily price by 9.09%. The company’s shares are currently down -98.38% year-to-date, but still up 35.37% over the last five days. On the other hand, Applied Dna Sciences Inc (NASDAQ:APDN) is 3.21% up in the 30-day period. We can see from the shorts that 0.48 million shares have been sold at a short interest cover period of 0.11 day(s).
The consensus price target as assigned by Wall Street analysts is $1.5, which translates to bulls needing to increase their stock price by 86.67% from its current value. Analyst projections state that APDN is forecast to be at a low of $1.5 and a high of $1.5.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Applied Dna Sciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -62.20 percent over the past six months and at a 88.16% annual growth rate that is well above the industry average of 12.00%. The year-over-year growth rate is expected to be -73.69%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 899k in revenue for the current quarter. 1 analysts expect Applied Dna Sciences Inc to make 1.18M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 779.74k and 891.16k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 15.29%. Forecasts for the next quarter put sales growth at 31.85%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 45.52%.
APDN Dividends
Applied Dna Sciences Inc’s next quarterly earnings report is expected to be released in January.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.62% of Applied Dna Sciences Inc shares, and 0.50% of them are in the hands of institutional investors. The stock currently has a share float of 0.50%. Applied Dna Sciences Inc stock is held by 23.0 institutions, with MATHER GROUP, LLC. being the largest institutional investor. By 2024-06-30, it held 0.0803% of the shares, which is about 700.0 shares worth $287.0.
